Weekly CFDA News Roundup (April 14th to April 21st)

Imported Medical Devices Account for 92% of Total Recalls in Shanghai
April 18, 2018
Monthly CFDA News Roundup (April)
May 9, 2018

Weekly CFDA News Roundup (April 14th to April 21st)

Weekly CFDA News Roundup covers policies, regulations, QA/recall/AE, and new approvals in medical device and IVD in China. It is edited by China Med Device, LLC, a consulting firm specializing in China CFDA regulatory, CRO and market access services.

Policy

CFDA issued Interpretation of Clinical Trials Quality Control for Medical Devices. It requires that, to ensure consistency of clinical trial protocols in two-site clinical trials, a lead entity shall be defined, and the clinical trial shall be conducted in the same period of time.

Guideline

CFDA issued 4 technical review guidelines, covering urology, gynecology and general devices.

  • Urology: technical review guideline on Insufflator
  • General: technical review guideline on medical cooler
  • Urology: technical review guideline on electrical urinometer
  • Gynecology: technical review guideline on electrical vaginal microscope

QA/Recall/AE

CFDA announced recall notices to 14 medical devices from 7 foreign manufactures and 4 local ones. Foreign manufacturers include:

  • Philips: infant incubator
  • Philips: x-ray angiographic system
  • Philips: defibrillator
  • Medtronic: heater/cooler system
  • Medtronic: plasma filter
  • Becton Dickinson: vacuum blood collection tube
  • Maquet: ventilator
  • Zimmer Biomet: hip stem
  • Beckman Coulter: automatic urine analyzer
  • Smith & Nephew: locking plate

 

Keep yourself updated with CFDA News Roundup, click HERE to opt-in. For market access newsletter, click HERE